Zacks Research Weighs in on Revvity, Inc.’s FY2024 Earnings (NYSE:RVTY)

Revvity, Inc. (NYSE:RVTYFree Report) – Equities research analysts at Zacks Research lifted their FY2024 EPS estimates for shares of Revvity in a research note issued on Monday, May 20th. Zacks Research analyst I. Bandyopadhyay now expects that the company will earn $4.64 per share for the year, up from their previous estimate of $4.62. The consensus estimate for Revvity’s current full-year earnings is $4.66 per share. Zacks Research also issued estimates for Revvity’s Q4 2024 earnings at $1.35 EPS, Q1 2025 earnings at $1.12 EPS, Q3 2025 earnings at $1.32 EPS, Q1 2026 earnings at $1.31 EPS and FY2026 earnings at $5.67 EPS.

Other research analysts also recently issued research reports about the stock. Robert W. Baird upped their price target on shares of Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 30th. KeyCorp upped their price target on shares of Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Stifel Nicolaus upped their target price on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a research report on Friday, February 2nd. TD Cowen upped their target price on shares of Revvity from $123.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, April 30th. Finally, Barclays upped their target price on shares of Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, January 25th. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Revvity currently has a consensus rating of “Moderate Buy” and a consensus target price of $118.17.

Read Our Latest Stock Analysis on RVTY

Revvity Stock Down 0.5 %

Shares of NYSE RVTY opened at $112.67 on Tuesday. The firm’s 50-day simple moving average is $104.43 and its 200 day simple moving average is $102.43. The company has a market cap of $13.90 billion, a price-to-earnings ratio of 93.12, a price-to-earnings-growth ratio of 2.91 and a beta of 1.09. The company has a quick ratio of 1.92, a current ratio of 2.23 and a debt-to-equity ratio of 0.40. Revvity has a 12-month low of $79.50 and a 12-month high of $131.96.

Revvity (NYSE:RVTYGet Free Report) last posted its earnings results on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.04. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The business had revenue of $649.90 million for the quarter, compared to analyst estimates of $646.83 million. During the same quarter in the prior year, the firm earned $1.01 EPS. The firm’s quarterly revenue was down 3.7% compared to the same quarter last year.

Institutional Trading of Revvity

Hedge funds have recently modified their holdings of the company. Parkside Financial Bank & Trust acquired a new stake in shares of Revvity in the 4th quarter valued at approximately $25,000. Gladius Capital Management LP increased its stake in Revvity by 84.1% during the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after purchasing an additional 106 shares in the last quarter. Benjamin F. Edwards & Company Inc. bought a new stake in Revvity during the 4th quarter worth approximately $27,000. CENTRAL TRUST Co bought a new stake in Revvity during the 4th quarter worth approximately $27,000. Finally, ORG Partners LLC bought a new stake in Revvity during the 4th quarter worth approximately $32,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be given a $0.07 dividend. The ex-dividend date is Friday, July 19th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.25%. Revvity’s dividend payout ratio is 23.14%.

About Revvity

(Get Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

See Also

Earnings History and Estimates for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.